YOUNG DAVID (Chief Executive Officer) purchased 20.7% of their position (1.81K shares) of PROCESSA PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $4.6K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/1/2026ACC: 0000897069-26-000756
DirectorOfficer· Chief Executive Officer
Since Oct 2020
+1.81K
Net shares
Net buyer
$4.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1.81K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.81K
Price / share
$2.54
Trade value
$4.59K
% of position
20.7%
3/31/2026
8.75K→10.56K
Total
Net shares
+1.81K
Net value
$4.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/31/2026 | P · Purchase | +1.81K | $2.54 | $4.59K | 20.7% | 8.75K | 10.56K |
| Total | +1.81K | $4.59K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned432.00
Common Stock
IndirectShares owned1.24K
Common Stock
IndirectShares owned742.00
Total
2.42K indirect2.42K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 432.00 | Indirect |
| Common Stock | 1.24K | Indirect |
| Common Stock | 742.00 | Indirect |
| Total | 2.42K | 2.42K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported